Evidence-Based Use of Rehabilitation Strategies Following
Stroke Alexander Dromerick, M.D. -- Associate
Professor of Neurology and Occupational Therapy
Washington University School of Medicine -- Presented September
21, 2004
References
Feeney DM, Gonzalez A, Law WA.
Amphetamine, haloperidol, and experience interact to affect
rate of recovery after motor cortex injury. Science.
1982 Aug 27;217(4562):855-7.
Stroemer RP, Kent TA, Hulsebosch CE.
Enhanced neocortical neural sprouting, synaptogenesis,
and behavioral recovery with D-amphetamine therapy after
neocortical infarction in rats. Stroke.
1998 Nov;29(11):2381-93.
Dhillon HS, Carbary T, Dose J, Dempsey RJ,
Prasad MR.
Activation of phosphatidylinositol bisphosphate signal
transduction pathway after experimental brain injury:
a lipid study. Brain
Res. 1995 Nov 6;698(1-2):100-6.
Hurwitz BE, Dietrich WD, McCabe PM, Alonso
O, Watson BD, Ginsberg MD, Schneiderman N.
Amphetamine promotes recovery from sensory-motor integration
deficit after thrombotic infarction of the primary somatosensory
rat cortex. Stroke.
1991 May;22(5):648-54.
Crisostomo EA, Duncan PW, Propst M, Dawson
DV, Davis JN.
Evidence that amphetamine with physical therapy promotes
recovery of motor function in stroke patients. Ann
Neurol. 1988 Jan;23(1):94-7.
Reding MJ
Neurology 1992; 42 (suppl 3): 329
Walker-Batson D, Smith P, Curtis S, Unwin
H, Greenlee R.
Amphetamine paired with physical therapy accelerates motor
recovery after stroke. Further evidence. Stroke.
1995 Dec;26(12):2254-9.
Sonde L, Nordstrom M, Nilsson CG, Lokk J,
Viitanen M.
A double-blind placebo-controlled study of the effects
of amphetamine and physiotherapy after stroke. Cerebrovasc
Dis. 2001;12(3):253-7.
Grade C, Redford B, Chrostowski J, Toussaint
L, Blackwell B.
Methylphenidate in early poststroke recovery: a double-blind,
placebo-controlled study. Arch
Phys Med Rehabil. 1998 Sep;79(9):1047-50.
Scheidtmann K, Fries W, Muller F, Koenig
E.
Effect of levodopa in combination with physiotherapy on
functional motor recovery after stroke: a prospective,
randomised, double-blind study. Lancet.
2001 Sep 8;358(9284):787-90.
van der Lee JH, Wagenaar RC, Lankhorst GJ,
Vogelaar TW, Deville WL, Bouter LM.
Forced use of the upper extremity in chronic stroke patients:
results from a single-blind randomized clinical trial. Stroke.
1999 Nov;30(11):2369-75.
Dromerick AW, Edwards DF, Hahn M.
Does the application of constraint-induced movement therapy
during acute rehabilitation reduce arm impairment after
ischemic stroke? Stroke.
2000 Dec;31(12):2984-8.
Gelber DA, Good DC, Dromerick A, Sergay
S, Richardson M.
Open-label dose-titration safety and efficacy study of
tizanidine hydrochloride in the treatment of spasticity
associated with chronic stroke. Stroke.
2001 Aug;32(8):1841-6.
Simpson DM, Alexander DN, O'Brien CF, Tagliati
M, Aswad AS, Leon JM, Gibson J, Mordaunt JM, Monaghan
EP.
Botulinum toxin type A in the treatment of upper extremity
spasticity: a randomized, double-blind, placebo-controlled
trial. Neurology.
1996 May;46(5):1306-10.
Lagalla G, Danni M, Reiter F, Ceravolo MG,
Provinciali L.
Post-stroke spasticity management with repeated botulinum
toxin injections in the upper limb. Am
J Phys Med Rehabil. 2000 Jul-Aug;79(4):377-84.
Bakheit AM, Thilmann AF, Ward AB, Poewe
W, Wissel J, Muller J, Benecke R, Collin C, Muller F,
Ward CD, Neumann C.
A randomized, double-blind, placebo-controlled, dose-ranging
study to compare the efficacy and safety of three doses
of botulinum toxin type A (Dysport) with placebo in upper
limb spasticity after stroke. Stroke.
2000 Oct;31(10):2402-6.
Childers MK, Brashear A, Jozefczyk P, Reding
M, Alexander D, Good D, Walcott JM, Jenkins SW, Turkel
C, Molloy PT.
Dose-dependent response to intramuscular botulinum toxin
type A for upper-limb spasticity in patients after a stroke. Arch
Phys Med Rehabil. 2004 Jul;85(7):1063-9.
Brashear A, Gordon MF, Elovic E, Kassicieh
VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C; Botox
Post-Stroke Spasticity Study Group.
Intramuscular injection of botulinum toxin for the treatment
of wrist and finger spasticity after a stroke. N
Engl J Med. 2002 Aug 8;347(6):395-400.
Pittock SJ, Moore AP, Hardiman O, Ehler
E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovsky
P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva
S, Stelmasiak Z, Zifko UA, Bhakta B, Coxon E.
A double-blind randomised placebo-controlled evaluation
of three doses of botulinum toxin type A (Dysport) in
the treatment of spastic equinovarus deformity after stroke. Cerebrovasc
Dis. 2003;15(4):289-300.
Meythaler JM, Guin-Renfroe S, Brunner RC,
Hadley MN.
Intrathecal baclofen for spastic hypertonia from stroke. Stroke.
2001 Sep;32(9):2099-109.
Francisco GE, Boake C.
Improvement in walking speed in poststroke spastic hemiplegia
after intrathecal baclofen therapy: a preliminary study. Arch
Phys Med Rehabil. 2003 Aug;84(8):1194-9.